Glycopyrrolate Transdermal Patch 1.5mg/day from Canada
Extended-release transdermal patch delivering 1.5mg glycopyrrolate daily for hyperhidrosis and sialorrhea via skin absorption affecting digestive glands. Form of transdermal system in measured doses under HTS 3004.90.92.57.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Adhesive matrix testing for skin irritation compliance
• Controlled substance checks if analogs trigger DEA rules
• Shelf-life extension data for patches mandatory